of a yellow Fe3tcitrate complex [calibration curve (A = 390 nm) was linear from 52.9 to 696.6 pmol/L, n = 8, r = 1.000; SD = 0.9; F = 263224.4; average relative error 0.3%]. Phosphate, which can interfere, is eliminated by precipitation.
Estimates that nearly 50% of hospitalized patients may be malnourished (1, 2) emphasize the need to monitor nutritional therapy. With a biological half-life of 1.9 d, transthyretin (prealbumin) is a sensitive biochemical marker for monitoring patients receiving total parenteral nutrition (3).
We have developed a turbidimetric immunoassay for measurement of serum transthyretin in the Cobas-Bio (Roche Analytical Instruments Inc., Nutley, NJ 07110). Calibrator for transthyretin (Atlantic Antibodies, Scarborough, ME 04074) was diluted in phosphate-buffered (pH 7.4) saline (PBS; per liter, 9 g of NaCl, 8 mmol of Na2HPO4, 1.5 mmol of KH2PO4, and 1 g of sodium azide) to prepare a sixconcentration curve, range 27 to 430 mgfL. A threefold dilution of goat antiserum to human transthyretin (Atlantic Antibodies) in Polyethylene Glycol 8000(40 g/L in PBS) was incubated at room temperature for 30 mm, then filtered through a 0.45-jim filter before analysis.
Microvolumes of calibrator or patients' sera (4 L) and PEG-PBS (200 L) were pipetted into the cuvette rotor. After a 180-s incubation at 25 #{176}C, sample-blank absorbance was measured at 340 rim and 75 1L of diluted antiserum was added. The sample-blank absorbance was then subtracted from the final absorbance, measured 480 s later. Concentrations for samples were calculated with the Cobas "DENS" program or from a manual log-log plot of concentration vs absorbance change. With this procedure, quantification of transthyretin is fast (>100 samples per hour), precise, and accurate. The relative ease with which the method can be performed increases its potential as a routine clinical assay of nutritional status.
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